
Welcome to this month’s ADVOCATE BRIEF
Welcome to the May Edition of The Archo Advocate Brief!
This month, the healthcare landscape is more dynamic than ever. From renewed scrutiny on prescription algorithms to state-led efforts to rein in private equity in care, May has brought both disruption and opportunity. At Archo, we’re especially energized as we count down to the release of our much-anticipated ELAVAY dataset—set to publish in just 30 days. This new body of data promises to deliver actionable insights into patient sentiment, care access, and systemic inequities, all through a lens of community-driven analytics. We’re excited to share findings that will not only inform our advocacy but also empower healthcare stakeholders nationwide. As always, this month’s brief distills key trends across policy, cost, equity, and technology—because understanding what’s next starts with knowing what’s now.
POLICY PULSE: POLITICAL
Shaping the Future of Healthcare Policy
Keeping up with healthcare policy changes is essential for understanding how new regulations and legal battles shape the industry. This month, we explore prescription algorithm oversight, major investigations into PBMs, and states taking action on healthcare ownership models.
Key Insights:
Prescription Algorithm Under Scrutiny: Advocates are pressing the FDA to regulate clinical decision algorithms, which, if unregulated, may compromise patient safety.
PBM Markups Spark Federal Action: An FTC report revealed 7,000% markups on generics and $7B in inflated drug costs—reigniting calls for PBM accountability.
State Pushback on Private Equity: Legislators in at least six states are moving to curb private equity’s influence in healthcare, aiming to protect patient-centered care.
Leading Through Policy Shifts: Jason Binder reflects on strategic pivots amid budget pressures and how adaptive leadership helps organizations stay ahead.
📌 Stay informed on healthcare policy and how it affects your organization.
COST OF CARE: ECONOMIC
The Price of Access: What’s Changing in Healthcare Costs?
From affordability concerns to insurance model reform, financial pressures continue to define the patient experience.
Key Insights:
Centering Patients in Value-Based Care: Health systems are recognizing that patient exclusion in the design of value-based care models limits effectiveness. The shift toward co-creating care models is underway.
Economic Pressure and System Redesign: New policy and cost realities are pushing healthcare organizations to innovate without increasing burdens on patients.
💡 Get expert perspectives on navigating the shifting cost landscape.
COMMUNITY LENS: SOCIOCULTURAL
Addressing Health Disparities in Our Communities
Healthcare is about more than treatments—it’s about inclusion, access, and ensuring all communities receive the support they need.
Key Insights:
(No new entries in April.)
We encourage you to stay connected to grassroots health equity efforts and share stories from your communities for upcoming editions.
🎤 ICYMI: At TEDx Charleston, Matt Toresco shared a compelling case for patient advocacy as a cornerstone of equitable healthcare transformation, reminding us that change begins when patients are empowered to lead.
📺 Watch the talk and join the movement. Watch Now
TECH TRENDS: TECHNOLOGY
How Technology is Transforming Healthcare
With the rise of AI-driven care decisions and algorithmic prescribing, healthcare innovation demands a balance between tech advancement and patient safety.
Key Insights:
The Algorithm Dilemma: Clinical decision support tools are entering widespread use, but oversight lags behind. Patient advocates and physicians are calling for immediate FDA attention to prevent harm.
Innovation Meets Regulation: The month’s tech coverage underscores the need for transparency and ethics in healthcare AI deployment.
🚀 Stay ahead with the latest in healthcare technology.
📣 Join the Conversation: Follow Archo Advocacy on LinkedIn for real-time updates on healthcare policy, costs, equity, and technology.
📧 Subscribe to Our Newsletter: Never miss an update—sign up for monthly insights into key healthcare trends.
📅 ELAVAY DATA LAUNCH: We’re excited to publish our ELAVAY data, providing insights on the rankings and impact of the patient advocacy function of pharma, biotech, medical device companies, payers, specialty pharmacies, and genomics laboratories.
Find out more on ELAVAY Here
1 For each of the articles noted in the report, find more here: https://docs.google.com/spreadsheets/d/1DN8QyfRGTCwNOypwUr-a8exTPTiCLh4HzgVhtB_6OOQ/edit?usp=sharing
